ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2481

Work Disability in a Cohort of Patients with Psoriatic Arthritis

Cecilia Zaffarana1, Osvaldo Luis Cerda1, Josefina Gallino Yanzi1, Margarita Landi1, Emilce Schneeberger1, Ignacio Carrillo1, María del Carmen Gonzalez Guzmán1, Jose A Maldonado Cocco1, Susana Gagliardi1 and Gustavo Citera2, 1Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Consultorios Reumatológicos Pampa, Buenos Aires, Argentina

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cross-sectional studies, Disease Activity, functional status and psoriatic arthritis, Work Disability

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Psychology/Social Sciences (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Several studies showed that unemployment and work disability are high in patients with Psoriatic Arthritis (PsA). Te purpose of this study is to evaluate work status in a cohort of patients with PsA and to identify variables associated to work disability.

Methods: A cross-sectional study was conducted including patients ≥ 18 years old with PsA according to classification criteria for Psoriatic Arthritis (CASPAR). Demographic data, disease duration, clinical features, articular and extra articular manifestations, comorbidities and current treatment were collected. Disease activity was assessed by the 66 swollen and 68 tender joint counts, DAS28, DAPSA, BASDAI and RAPID3. Quality of life was assessed using DLQI and PsAQoL questionnaires.  Functional capacity was assessed by HAQ and BASFI. Skin involvement was evaluated using PASI. Presence of dactylitis  and enthesitis (MASES) were evaluated. Statistical analysis: T test, Mann Whitney, Chi2 and Fisher exact test. Multiple logistic regression analysis to explore factors associated to work disability.

Results: 87 patients with PsA were evaluated. Median age was 52 years (IQR 40.2-61.7). 28 patients (32.2%) were unemployed and 18 of them (20.6%) were unemployed due to PsA, 10  were retired. Unemployed patients had a lower age at  disease onset  (33.9 ± 12.28 vs 38.87 ± 11.91, p=0.042), higher disease activity  (BASDAI 5.7 ± 2.9 vs 4.06 ± 2.8, p=0.03, RAPID3 13.99 ± 7.4, vs 10.5 ± 6.27 p=0.03, DAPSA 20.5 ± 10.7 vs 16.5 ± 5.16 p=0.04, DAS28 4.2 ± 1.3 vs 3.44 ± 1.4, p=0.032), worse functional status (HAQ 1.18 ± 0.8 vs 0.68 ± 0.6, p=0.006) and worse quality of life (PsAQoL 12.1 ± 3.7 vs 6.56 ± 6, p<0.001). In the multivariate analysis, lower age  [OR 0.9 (CI 95% 0.8-0.9), p=0.004] and worse functional status [HAQ OR 7.1 (IC 95% 1.9-25.7), p=0.003] were independently associated with WD.

Conclusion: In our cohort the prevalence of work disability  attributed to PsA was 20.6%, and it was associated to lower age and worse functional capacity.


Disclosure: C. Zaffarana, None; O. L. Cerda, None; J. Gallino Yanzi, None; M. Landi, None; E. Schneeberger, None; I. Carrillo, None; M. D. C. Gonzalez Guzmán, None; J. A. Maldonado Cocco, None; S. Gagliardi, None; G. Citera, None.

To cite this abstract in AMA style:

Zaffarana C, Cerda OL, Gallino Yanzi J, Landi M, Schneeberger E, Carrillo I, Gonzalez Guzmán MDC, Maldonado Cocco JA, Gagliardi S, Citera G. Work Disability in a Cohort of Patients with Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/work-disability-in-a-cohort-of-patients-with-psoriatic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/work-disability-in-a-cohort-of-patients-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology